Responses
Clinical and epidemiological research
Concise report
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Compose a Response to This Article
Other responses
No responses have been published for this article.